Literature DB >> 4149420

Interindividual differences in drug oxidation: clinical importance.

F Sjöqvist, C von Bahr.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4149420

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  22 in total

Review 1.  Drug pharmacokinetics in the postoperative period.

Authors:  J Elfstrom
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

2.  The effects of hypnotics on imipramine treatment.

Authors:  B R Ballinger; A Presly; A H Reid; I H Stevenson
Journal:  Psychopharmacologia       Date:  1974

3.  Disappearance of phenazone from plasma in patients with obstructive jaundice.

Authors:  J Elfström; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

4.  Gas chromatographic assessment of the reproducibility of phenazone plasma half-life in young healthy volunteers.

Authors:  S Lindgren; P Collste; B Norlander; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 5.  Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.

Authors:  R L Parsons
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation.

Authors:  L Ost; I Björkhem; C von Bahr
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.

Authors:  L F Gram; P B Andreasen; K F Overo; J Christiansen
Journal:  Psychopharmacology (Berl)       Date:  1976-10-20       Impact factor: 4.530

8.  Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses.

Authors:  P Collste; M Garle; M D Rawlins; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

9.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

10.  Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.

Authors:  N Buchanan; M Davis; M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.